These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9329722)

  • 41. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
    Czech C; Mönning V; Tienari PJ; Hartmann T; Masters C; Beyreuther K; Förstl H
    Lancet; 1993 Nov; 342(8882):1309. PubMed ID: 7901624
    [No Abstract]   [Full Text] [Related]  

  • 42. APOE genotype, vascular risk factors, memory test performance and the five-year risk of vascular cognitive impairment or Alzheimer's disease.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2005; 20(5):292-7. PubMed ID: 16166776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Apolipoprotein E 4 gene is a risk factor for Alzheimer's disease].
    Peng D; Xu X; Feng Y
    Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):688-90. PubMed ID: 11769724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. APOE epsilon 4 allele in Alzheimer's and non-Alzheimer's dementias.
    Itabashi S; Arai H; Higuchi S; Sasaki H; Trojanowska JQ
    Lancet; 1996 Oct; 348(9032):960-1. PubMed ID: 8843828
    [No Abstract]   [Full Text] [Related]  

  • 45. Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population.
    Cornelius C; Fastbom J; Winblad B; Viitanen M
    Neuroepidemiology; 2004; 23(3):135-43. PubMed ID: 15084783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.
    Sleegers K; Roks G; Theuns J; Aulchenko YS; Rademakers R; Cruts M; van Gool WA; Van Broeckhoven C; Heutink P; Oostra BA; van Swieten JC; van Duijn CM
    Brain; 2004 Jul; 127(Pt 7):1641-9. PubMed ID: 15130954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [An association analysis of apolipoprotein E genotypes with Alzheimer's disease in Chinese population].
    Wu YN; Zhang JW; Zhang ZX; Qu QM; Chen D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):450-4. PubMed ID: 12905860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Apolipoprotein E genotypes in patients investigated for dementia].
    Johannsen P; Jakobsen JK; Jørgensen AL
    Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's disease.
    Holmes C; Russ C; Kirov G; Aitchison KJ; Powell JF; Collier DA; Lovestone S
    Biol Psychiatry; 1998 Feb; 43(3):159-64. PubMed ID: 9494696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions.
    Egensperger R; Bancher C; Kösel S; Jellinger K; Mehraein P; Graeber MB
    Biochem Biophys Res Commun; 1996 Jul; 224(2):484-6. PubMed ID: 8702415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apolipoprotein E epsilon 4 allele and whole brain atrophy in late-onset Alzheimer's disease.
    Yasuda M; Mori E; Kitagaki H; Yamashita H; Hirono N; Shimada K; Maeda K; Tanaka C
    Am J Psychiatry; 1998 Jun; 155(6):779-84. PubMed ID: 9619150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective effect of apoE epsilon 2 in Alzheimer's disease.
    Benjamin R; Leake A; McArthur FK; Ince PG; Candy JM; Edwardson JA; Morris CM; Bjertness E
    Lancet; 1994 Aug; 344(8920):473. PubMed ID: 7914580
    [No Abstract]   [Full Text] [Related]  

  • 53. Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.
    Tisato V; Zuliani G; Vigliano M; Longo G; Franchini E; Secchiero P; Zauli G; Paraboschi EM; Vikram Singh A; Serino ML; Ortolani B; Zurlo A; Bosi C; Greco A; Seripa D; Asselta R; Gemmati D
    PLoS One; 2018; 13(3):e0193867. PubMed ID: 29518107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
    Lucotte G; David F; Visvikis S; Leininger-Müller B; Siest G; Babron MC; Couderc R
    Lancet; 1993 Nov; 342(8882):1309. PubMed ID: 7901625
    [No Abstract]   [Full Text] [Related]  

  • 55. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.
    Landén M; Thorsell A; Wallin A; Blennow K
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):352-6. PubMed ID: 8890772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex.
    Qiu C; Kivipelto M; Agüero-Torres H; Winblad B; Fratiglioni L
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):828-33. PubMed ID: 15145993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals.
    Rebeck GW; Perls TT; West HL; Sodhi P; Lipsitz LA; Hyman BT
    Neurology; 1994 Aug; 44(8):1513-6. PubMed ID: 8058160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Susceptibility genetics in the etiopathogenesis of Alzheimer's disease: role for potential confounding factors.
    Harrington CR; Roth M
    Int Psychogeriatr; 1997 Sep; 9(3):229-44. PubMed ID: 9513025
    [No Abstract]   [Full Text] [Related]  

  • 60. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
    Amouyel P; Brousseau T; Fruchart JC; Dallongeville J
    Lancet; 1993 Nov; 342(8882):1309. PubMed ID: 7901623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.